PULMONARY SARCOIDOSIS
Clinical trials for PULMONARY SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY SARCOIDOSIS trials appear
Sign up with your email to follow new studies for PULMONARY SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may help sarcoidosis patients taper steroids
Disease control Recruiting nowThis study tests a new medicine called XTMAB-16 in people with pulmonary sarcoidosis, a condition causing lung inflammation. The goal is to see if it is safe and can help reduce the need for steroids. About 94 adults aged 18-80 will take part. The drug is given in increasing dose…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated May 17, 2026 16:12 UTC
-
New pill could tame lung inflammation in sarcoidosis
Disease control Recruiting nowThis study tests an experimental oral drug called OATD-01 for people with active pulmonary sarcoidosis, a condition causing lung inflammation. About 96 adults will receive either the drug or a placebo for 12 weeks to see if it reduces disease activity measured by PET scans. The g…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Scientists hunt for lung disease genes in 3,500 volunteers
Knowledge-focused Recruiting nowThis study looks at how genes play a role in lung diseases like cystic fibrosis, asthma, and pulmonary fibrosis. Researchers will analyze DNA from up to 3,500 people, including healthy volunteers, to find genetic differences linked to lung problems. A small optional part of the s…
Matched conditions: PULMONARY SARCOIDOSIS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC